Updated November 2014
- Vision: Global Leader in Innovative Health Research
- Mission statement: Strengthen R&D ability to cope with public health crises; Develop innovative health technology; Establish infrastructure for health research
- Organisational status: The KNIH is a sole government research institute in health technology under the supervision of Ministry of Health and Welfare. KNIH has four centers and two divisions related to infectious disease, immunology & pathology, biomedical science and genome science. To support strategic R&D research to improve public health, and applies on the medical industry to contribute quality of life, we focuses on TOP 5 green projects: Genome Research, Rare Disease & Stem Cell Research, Emerging Disease Vaccine Research, Environment (Climate) Change Adaption Research and NCDs and Aging.
- Remit: National research institute for infectious disease and biomedical science and infrastructure to support research biomedical research.
- Web link to organisation’s home page : http://www.nih.go.kr
Annual Research Budget of KNIH
36.8 mil. USD
Stem Cell Budget
8.25 mil USD
Stem Cell Strategy
- KNIH aims to establish national infrastructure to support stem cell and regenerative medicine
- Human embryonic stem cell registry authorized by Bioethics and Safety Act (http://kscr.nih.go.kr) and National Stem Cell Bank for hESC and hiPSC management, quality control and distribution
- KNIH is constructing the National Center for Stem Cell and Regenerative Medicine where GMP facility for stem cell banking is included
Recent Research Achievements and Outputs
- MOU with BCRT(German), NIBIO(Japan), NIBSC(UK) and EOI with NIH(USA)
- Established research grade stem cell banking SOPs
- Co-organization of 2014 Korea Society of Stem Cell Research annual meeting (KSSCR)
New Funding Initiatives
- Funding for maintaining National Stem Cell Bank and constructing National Center for Stem Cell and Regenerative Medicine was initiated in 2012. 2014 funding amounts are; 1.45 mil USD for the Stem Cell Bank and 7.8 mil USD for the Construction.
- Funding for clinical grade-, HLA homozygous iPSC establishment (0.8mil USD/year, for 2 years) was initiated in 2013 in collaboration with Ministry of Health and Welfare. This project is continued in 2014.
National (or Regional) Stem Cell Network or Contact Point
Stem cell network
Global Stem Cell and Regenerative Medicine Acceleration Center (http://gsrac.org)
Korean Society for Stem Cell Research (http://www.ksscr.org)
Other Major Funders of Stem Cell Research
Ministry of Health and Welfare (http://english.mohw.go.kr, 15.5 mil USD for the new projects, 17.5 mil USD for the continuing projects in ’14.
Previous Member Updates